During the past decade, Moscow City Clinical Hospital No.51 conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moscow City Clinical Hospital No.51" #1 sponsor was "Mannkind Corporation" with 6 trials, followed by "Actelion" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Ferring Pharmaceuticals" with 3 trials sponsored and "Kowa Research Europe" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moscow City Clinical Hospital No.51" #1 collaborator was "Bayer" with 2 trials as a collaborator, "AcitGraph" with 1 trials as a collaborator, "Almac Clinical Technologies, LLC" with 1 trials as a collaborator, "Chiltern International Ltd." with 1 trials as a collaborator and "Covance Central Laboratory Services, LP" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Moscow City Clinical Hospital No.51" are "Crohn Disease" (3 trials), "Dyslipidemia" (3 trials), "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Diabetes Type 2" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Moscow City Clinical Hospital No.51" in a lesser frequency.

Most popular intervention types in "Moscow City Clinical Hospital No.51" are "Drug" (24 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "Pitavastatin" (3 trials), "Technosphere Insulin" (3 trials) and "Interferon beta-1a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Moscow City Clinical Hospital No.51" are 24 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Moscow City Clinical Hospital No.51". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Moscow City Clinical Hospital No.51, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Moscow City Clinical Hospital No.51, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".